Literature DB >> 3822124

Contrasting monoamine oxidase activity and tyramine induced catecholamine release in PC12 and chromaffin cells.

M B Youdim, E Heldman, H B Pollard, P Fleming, E McHugh.   

Abstract

PC12 (phaeochromocytoma derived) cells possess the catecholamine synthesizing enzymes as well as the ability to store and release the catecholamines in response to K+. However, their monoamine oxidase activity and catecholamine release in response to tyramine has not been examined previously. PC12 cells have monoamine oxidase activity which oxidizes type A (noradrenaline and serotonin) and type A-B (dopamine, tyramine and kynuramine) substrates, and is selectively inhibited by clorgyline (IC50 approximately 10(-6) M). In contrast, PC12 cell monoamine oxidase hardly oxidizes phenylethylamine a type B substrate, and is relatively insensitive to inhibition by the selective monoamine oxidase type B inhibitor, 1-deprenyl (IC50 approximately 10(-6) M). By the above criteria it is apparent that the monoamine oxidase in PC12 is solely type A. The kinetics of the oxidase are similar to those of monoamine oxidase type A reported in other tissues including the adrenergic neuron, having apparent Km values of 400, 280, 170 and 227 microM for noradrenaline, dopamine, serotonin and tyramine. The apparent Km value for phenylethylamine is 235 microM. On the other hand, isolated chromaffin cells have the B form of monoamine oxidase with high affinity (Km approximately 25 microM) for phenylethylamine and low affinities for noradrenaline (Km approximately 1100 microM) and adrenaline (Km approximately 1700 microM). This enzyme form is selectively inactivated by the monoamine oxidase type B inhibitor, 1-deprenyl. In similar fashion to peripheral adrenergic neurons, PC12 cells share the capacity to express a tyramine releasable pool of catecholamines, a property entirely lacking in mature cultured chromaffin cells, even though the latter cells are capable of taking up tyramine by a cocaine sensitive process.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3822124     DOI: 10.1016/0306-4522(86)90145-4

Source DB:  PubMed          Journal:  Neuroscience        ISSN: 0306-4522            Impact factor:   3.590


  8 in total

1.  Simulated microgravity conditions enhance differentiation of cultured PC12 cells towards the neuroendocrine phenotype.

Authors:  P I Lelkes; D L Galvan; G T Hayman; T J Goodwin; D Y Chatman; S Cherian; R M Garcia; B R Unsworth
Journal:  In Vitro Cell Dev Biol Anim       Date:  1998-04       Impact factor: 2.416

2.  Receptor subtype-induced targeting and subtype-specific internalization of human alpha(2)-adrenoceptors in PC12 cells.

Authors:  T Olli-Lähdesmäki; J Kallio; M Scheinin
Journal:  J Neurosci       Date:  1999-11-01       Impact factor: 6.167

3.  Increased cell-cell adhesion, a novel effect of R-(-)-deprenyl.

Authors:  V Jenei; K Zor; K Magyar; J Jakus
Journal:  J Neural Transm (Vienna)       Date:  2005-03-23       Impact factor: 3.575

4.  Mitochondrial membrane potential and nuclear changes in apoptosis caused by serum and nerve growth factor withdrawal: time course and modification by (-)-deprenyl.

Authors:  J S Wadia; R M Chalmers-Redman; W J Ju; G W Carlile; J L Phillips; A D Fraser; W G Tatton
Journal:  J Neurosci       Date:  1998-02-01       Impact factor: 6.167

Review 5.  The molecular basis of familial dysautonomia: overview, new discoveries and implications for directed therapies.

Authors:  Berish Y Rubin; Sylvia L Anderson
Journal:  Neuromolecular Med       Date:  2007-11-06       Impact factor: 3.843

6.  Cell Models for the Study of Sex Steroid Hormone Neurobiology.

Authors:  Chang Su; Nataliya Rybalchenko; Derek A Schreihofer; Meharvan Singh; Babak Abbassi; Rebecca L Cunningham
Journal:  J Steroids Horm Sci       Date:  2012

7.  Differential Susceptibilities of Catecholamines to Metabolism by Monoamine Oxidases.

Authors:  David S Goldstein; Genessis Castillo; Patti Sullivan; Yehonatan Sharabi
Journal:  J Pharmacol Exp Ther       Date:  2021-09-09       Impact factor: 4.402

8.  Pathological changes in platelet histamine oxidases in atopic eczema.

Authors:  R Kiehl; G Ionescu
Journal:  Mediators Inflamm       Date:  1993       Impact factor: 4.711

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.